(3-methyl-1-benzothiophen-2-yl)boronic acid 912331-27-2 boronic acid,3-methyl-benzo[b]thiophene-2-yl;_x000D_ 3-Methyl-benzo[b]thiophene-2-boronic acid;_x000D_ (3-Methylbenzo[b]thiophen-2-yl)boronic acid;

Quinazolin-8-ol 7557-02-0 quinazolin-8-ol;

3-Phenylpropiolonitrile 935-02-4 3-phenylprop-2-ynenitrile;

6-Methoxytryptamine 3610-36-4 1H-Indole-3-ethanamine, 6-methoxy-;_x000D_ 3-(2-Aminoethyl)-6-methoxyindole;_x000D_ 2-(6-Methoxy-1H-indol-3-yl)ethanamine;

2-Bromo-5-nitro-3-(trifluoromethyl)pyridine 956104-42-0 W9760;

cyazofamid 120116-88-3 4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide;_x000D_ Fendazosulam;_x000D_ Cyazofamid solution;_x000D_ 4-chloro-2-cyano-N,N-dimethyl-5-(4-methylphenyl)-1H-imidazole-1-sulfonamide;_x000D_ Docious;_x000D_ Mildicut;_x000D_ Cyazofamid;_x000D_ 4-chloro-2-cyano-N,N-dimethyl-5-(4-methylphenyl)imidazole-1-sulfonamide;

[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]methyl-triphenylphosphanium,bromide 885477-83-8 Rosuvastatin Intermediate Z-8.2;_x000D_ [[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]methyl]triphenylphosphonium bromide;_x000D_ Rosuvastatin Triphenylphosphonium Bromide;_x000D_ ((4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)methyl)triphenylphosphonium bromide;

alcaftadine 147084-10-4 Lastacaft;_x000D_ 11-(1-methylpiperidin-4-ylidene)-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde;_x000D_ alcaftadina;_x000D_ alcaftadinum;_x000D_ UNII-7Z8O94ECSX;_x000D_ Vilasta;_x000D_ Alcaftadine;

1-(2-chloro-4-fluorophenyl)cyclopropan-1-amine 920501-75-3 Cyclopropanamine,1-(2-chloro-4-fluorophenyl);

1-(3,3-dimethylcyclohexyl)ethyl formate 25225-08-5 cyclohexanemethanol,|A,3,3-trimethyl-,formate;_x000D_ Cyclohexanemethanol,?,3,3-trimethyl-,formate;_x000D_ EINECS 246-735-2;